Search:
 

Evaluation

For an alliance whose innovative methods are often held up as models for others to imitate, it is essential that GAVI evaluates "lessons learned". It does this through commissioned studies and is guided by its evaluation policy.

From new types of funding to ground-breaking partnerships, the GAVI Alliance has built a reputation for "thinking outside the box" in its efforts to deliver life-saving vaccines in the world’s poorest countries. Evaluation offers the Alliance the opportunity to measure what has worked and why.

Evaluation studies

The GAVI Alliance commissioned evaluations of: (see request for proposal PDF - 244K).

  • The Accelerated Development and Introduction of Priority New Vaccines (ADIPs), the Hib Initiative, and related support for the introduction of new vaccines
  • Immunisation Services Support (ISS)
  • GAVI Phase One (2000-2005).

Here is the latest on these three evaluations which were overseen by the GAVI Evaluation Steering Committee:

  1. The Accelerated Development and Introduction of Priority New Vaccines (ADIPs), the Hib Initiative, and related support for the introduction of new vaccines.

    The ADIPs evaluation study was completed, the report (PDF - 390K)endorsed by the board in May 2007 and a managerial response (PDF - 56K) given.

  2. Immunisation Services Support (ISS).

    Summary of results and findings
    The evaluation report (PDF - 628K) was completed, and then went through a review process by the ISS Steering Committee (September 2007) and the GAVI Working Group (October 2007). The GAVI Senior Management team prepared a formal response (Excel - 32K) to the recommendations for the GAVI Alliance Boards in November 2007. Work is ongoing to implement the agreed recommendations and develop the further actions required.

  3. GAVI Phase One (2000-2005).

    The evaluation report (PDF - 3MB) was completed, and after a review process by the GAVI Evaluation Steering Committee, was adopted by the GAVI Board in October 2008.

The GAVI Alliance has also commissioned an evaluation of the GAVI Alliance's Injection Safety Support (INS). See RFP (PDF - 103K). This evaluation is also being overseen by the Evaluation of GAVI's Injection Safety Support Steering Committee and will result in a report.

GAVI's evaluation policy

The GAVI Alliance evaluation policy (PDF - 57K) guides how GAVI accesses its activities from 2008 onwards (GAVI phase 2).

The policy has been developed by the GAVI secretariat and the Monitoring and Evaluation Technical Advisory Group (METAG) and has been reviewed by the GAVI Working Group.

Criteria

As well as defining the objectives of GAVI evaluations in the context of the alliance’s overall mission, the policy also identifies which GAVI activities will be assessed; this list includes projects, programmes and policies.

Criteria for each evaluation include relevance, efficiency, effectiveness, impact – negative or positive – and sustainability.

The policy also helps the alliance consider when evaluations should be carried out and by whom: during a policy’s implementation or afterwards; by internal staff or outsourced; in a participatory manner or jointly among partners.

Knowledge-sharing

The policy also enables partners to carry out their own evaluations, emphasizing the importance of knowledge-sharing across the Alliance. It also outlines how external evaluators should be selected and gives guidance on conflict of interest and transparency issues.

All GAVI evaluations are carried out according to international standards, guaranteeing independence, impartiality and transparency.